Cargando…

Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

PURPOSE: Appropriate gentamicin dosing in continuous renal replacement therapy (CRRT) patients remains undefined. This study aimed to develop a population pharmacokinetic (PK) model of gentamicin in CRRT patients and to infer the optimal dosing regimen for gentamicin. METHODS: Fourteen CRRT patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Sha, Cheng, Zeneng, Xie, Feifan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747548/ https://www.ncbi.nlm.nih.gov/pubmed/35023902 http://dx.doi.org/10.2147/DDDT.S343385

Ejemplares similares

Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: Schatz, Lea Marie, et al.
Publicado: (2023)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Evaluation of gentamicin first-dose pharmacokinetics in septic critically ill patients: pilot study
por: Pereira, JC Gonçalves, et al.
Publicado: (2009)

Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
por: Broeker, A., et al.
Publicado: (2018)

Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial
por: Onichimowski, Dariusz, et al.
Publicado: (2020)

Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
por: Wenzler, Eric, et al.
Publicado: (2021)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019)

Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy
por: Kiser, Tyree H, et al.
Publicado: (2015)

Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
por: Wenzler, Eric, et al.
Publicado: (2022)

Pharmacokinetics of gentamicin and vancomycin during continuous venovenous hemofiltration in critically ill septic patients with acute kidney injury
por: Petejova, N, et al.
Publicado: (2013)

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation
por: Mariat, Christophe, et al.
Publicado: (2006)

Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy
por: Xu, Xiaoying, et al.
Publicado: (2016)

Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy
por: Hahn, Jongsung, et al.
Publicado: (2021)

Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
por: Roger, C, et al.
Publicado: (2015)

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Samtani, Mahesh N., et al.
Publicado: (2012)

Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2020)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children
por: Li, SiChan, et al.
Publicado: (2021)

External Evaluation of Population Pharmacokinetic Models of Methotrexate for Model-Informed Precision Dosing in Pediatric Patients with Acute Lymphoid Leukemia
por: Wang, Shengfeng, et al.
Publicado: (2023)

Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?
por: Roberts, Jason A, et al.
Publicado: (2014)

1298. Population Pharmacokinetics of Ceftazidime-avibactam among Critically-ill Patients with and without Receipt of Continuous Renal Replacement Therapy
por: Kline, Ellen G, et al.
Publicado: (2020)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

Dose Optimization of Teicoplanin for Critically Ill Patients With Renal Dysfunction and Continuous Renal Replacement Therapy: Experience From a Prospective Interventional Study
por: Shi, Lu, et al.
Publicado: (2022)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Sime, Fekade B., et al.
Publicado: (2019)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
por: Garreau, Romain, et al.
Publicado: (2021)

Vitamin D serum levels in multiorgan failure critically ill patients undergoing continuous renal replacement therapies
por: Czarnik, Tomasz, et al.
Publicado: (2020)

Adjuvant Vitamin C in critically ill patients undergoing renal replacement therapy: What’s the right dose?
por: Marik, Paul E, et al.
Publicado: (2018)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)

Evaluation of Pharmacokinetic Drug–Drug Interactions: A Review of the Mechanisms, In Vitro and In Silico Approaches
por: Peng, Yaru, et al.
Publicado: (2021)

Optimizing the dosing regimen of linezolid in critically ill septic patients undergoing continuous hemodiafiltration using a pharmacokinetic/pharmacodynamic analysis and monte carlo simulation
por: Barrasa González, H, et al.
Publicado: (2015)

Population-Based Pharmacokinetics and Dose Optimization of Imipenem in Vietnamese Critically-Ill Patients
por: Dinh, Thanh D, et al.
Publicado: (2022)

Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients
por: Liang, Danhong, et al.
Publicado: (2023)

Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation
por: Ghoneim, Ragia H., et al.
Publicado: (2021)

Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy
por: Chen, Jiaojiao, et al.
Publicado: (2022)

An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration
por: Spooner, Almath M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7lq63sbu4bdhs9usvkk53kugtq